TYK Medicines, Inc (HKG:2410)
Hong Kong
· Delayed Price · Currency is HKD 9.97
-0.15 (-1.48%)
Apr 29, 2026, 4:08 PM HKT
TYK Medicines Market Cap
TYK Medicines has a market cap or net worth of 3.84 billion as of April 29, 2026. Its market cap has decreased by -70.54% in one year.
Market Cap
3.84B
Enterprise Value
3.60B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
9.97
Market Cap Chart
Since August 20, 2024, TYK Medicines's market cap has decreased from 5.08B to 3.84B, a decrease of -24.51%. That is a compound annual growth rate of -15.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 3.89B | -21.87% |
| Dec 31, 2025 | 4.98B | -71.50% |
| Dec 31, 2024 | 17.48B | 244.16% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Qyuns Therapeutics | 3.90B |
| BioDlink International Company | 3.77B |
| Clover Biopharmaceuticals | 3.71B |
| Mirxes Holding Company | 3.66B |
| Viva Biotech Holdings | 3.61B |
| Shandong Boan Biotechnology | 4.24B |
| Antengene Corporation | 3.44B |
| Jiangsu Recbio Technology | 3.13B |